Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.

@article{Cassaday2016EvaluationOA,
  title={Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.},
  author={Ryan D Cassaday and D Alan Potts and Philip A Stevenson and Merav Bar and George E Georges and Andrei R. Shustov and Mohamed L Sorror and Brent L Wood and Colleen Delaney and Kristine C. Doney and Rainer F Storb and Brenda M Sandmaier},
  journal={Leukemia & lymphoma},
  year={2016},
  volume={57 9},
  pages={2109-18}
}
Comparisons without hematopoietic cell transplantation (HCT) to myeloablative (MAC) or reduced-intensity HCT (RIC) for adults with acute lymphoblastic leukemia (ALL) in first minimal-residual-disease negative remission (MRD(Neg) CR1) are limited. Further, the importance of MRD(Neg) following salvage therapy (MRD(Neg) CR2+) is unknown. We evaluated 89… CONTINUE READING